Ukwelashwa komdlavuza muva nje kuguquke ngendlela emangalisayo; enye yentuthuko ebaluleke kakhulu itholwe ngezindlela zokwelashwa kwe-immunotherapy ezingeni lamaselula. I-B-Cell Leukemia ihlukaniswa kuwo wonke umdlavuza wegazi ngenxa yezinkinga zayo ezihlukile nezimpendulo ekwelashweni. Lesi simo, ikakhulukazi esibangelwa ukwanda kwama-lymphocyte e-B egazini, sizovuselela izindlela ezintsha zokucabanga ngokulwa nesifo nokuthuthukisa imiphumela yeziguli. Ucwaningo oluqhubekayo luyenziwa ukuze kukhishwe izindima ezintsha ze-B-Cell ekwelapheni izindlela zokwelapha ezisekelwe ku-pathology ezenziwe ngendlela efanele ukuze kusetshenzwe mayelana nezinqubo eziwumsuka walesi sifo. I-Beijing BIOOCUS Biotech Ltd. iphambili kulo mkhuba wokuziphendukela kwemvelo, yenza ucwaningo nokuthuthukiswa kwezindlela zokwelapha ezivikela umzimba kumaselula, futhi kunemizamo eyize yokuhlangabezana nezinselele ze-B-Cell Leukemia. Inkampani ehamba phambili ye-biotech eShayina nayo izishaya isifuba ngokuba yibhizinisi elinenani eliphelele elinesikhungo sokucwaninga esiphethwe nguwe, indawo ye-GMP, inkundla ye-CDMO, kanye nenkundla yokudlulisa ubuchwepheshe. Isithembiso sethu sokwelashwa kwe-B-Cell Leukemia sidlula amazinga okusinda; kudlulela ekwenzeni ukwelashwa kube yinto ejabulisa kakhudlwana ezigulini, ngamasu amasha naqondene nawe.